APO Research
Talk to an analyst

APO RESEARCH · REPORT

Perphenazine Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Perphenazine Drug Industry Growth and Trends Forecast to 2032

2 January 202691 pages

Choose your research edition.

Industry ResearchPerphenazine Drug Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Perphenazine Drug Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Perphenazine Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Perphenazine Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Perphenazine Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Perphenazine Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Perphenazine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Perphenazine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Perphenazine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Perphenazine Drug include Teva, Sandoz, Shandong Boshan Pharma, ZHPHARMA, Viatris and Endo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Perphenazine Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Perphenazine Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Perphenazine Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Perphenazine Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Perphenazine Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Perphenazine Drug Market by Company

Teva

Sandoz

Shandong Boshan Pharma

ZHPHARMA

Viatris

Endo

Perphenazine Drug Segment by Type

Oral Forms

Injectable Solution

Perphenazine Drug Segment by Application

Psychosis

Antiemetic

Perphenazine Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Perphenazine Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Perphenazine Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Perphenazine Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Perphenazine Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Perphenazine Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Forms Table 2. Major Company of Injectable Solution Table 3. Global Perphenazine Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Perphenazine Drug Sales by Type (2021-2026) & (K Units) Table 5. Global Perphenazine Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global Perphenazine Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global Perphenazine Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global Perphenazine Drug Price by Type (2021-2026) & (US$/Unit) Table 9. Global Perphenazine Drug Sales by Type (2027-2032) & (K Units) Table 10. Global Perphenazine Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global Perphenazine Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global Perphenazine Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global Perphenazine Drug Price by Type (2027-2032) & (US$/Unit) Table 14. North America Perphenazine Drug Sales by Type (2021-2026) & (K Units) Table 15. North America Perphenazine Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Perphenazine Drug Sales by Type (2021-2026) & (K Units) Table 17. Europe Perphenazine Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Perphenazine Drug Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Perphenazine Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Perphenazine Drug Sales by Type (2021-2026) & (K Units) Table 21. Latin America Perphenazine Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Perphenazine Drug Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Perphenazine Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Perphenazine Drug Industry Trends Table 25. Perphenazine Drug Industry Drivers Table 26. Perphenazine Drug Industry Opportunities and Challenges Table 27. Perphenazine Drug Industry Restraints Table 28. Global Perphenazine Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Perphenazine Drug Revenue Market Share by Company (2021-2026) Table 30. Global Perphenazine Drug Sales by Company (2021-2026) & (K Units) Table 31. Global Perphenazine Drug Sales Share by Company (2021-2026) Table 32. Global Perphenazine Drug Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Perphenazine Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Perphenazine Drug Major Company Production Sites and Headquarters Table 35. Global Perphenazine Drug Company, Product Type & Application Table 36. Global Perphenazine Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Perphenazine Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Perphenazine Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Perphenazine Drug Sales by Region (2021-2026) & (K Units) Table 41. Global Perphenazine Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global Perphenazine Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global Perphenazine Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global Perphenazine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Perphenazine Drug Sales by Region (2027-2032) & (K Units) Table 46. Global Perphenazine Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global Perphenazine Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global Perphenazine Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global Perphenazine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Perphenazine Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Perphenazine Drug Sales by Application (2021-2026) & (K Units) Table 52. Global Perphenazine Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global Perphenazine Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global Perphenazine Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global Perphenazine Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global Perphenazine Drug Sales by Application (2027-2032) & (K Units) Table 57. Global Perphenazine Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global Perphenazine Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global Perphenazine Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global Perphenazine Drug Price by Application (2027-2032) & (US$/Unit) Table 61. North America Perphenazine Drug Sales by Application (2021-2026) & (K Units) Table 62. North America Perphenazine Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Perphenazine Drug Sales by Application (2021-2026) & (K Units) Table 64. Europe Perphenazine Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Perphenazine Drug Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Perphenazine Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Perphenazine Drug Sales by Application (2021-2026) & (K Units) Table 68. Latin America Perphenazine Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Perphenazine Drug Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Perphenazine Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Perphenazine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Teva Perphenazine Drug Product Portfolio Table 75. Teva Recent Development Table 76. Sandoz Company Information Table 77. Sandoz Business Overview Table 78. Sandoz Perphenazine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sandoz Perphenazine Drug Product Portfolio Table 80. Sandoz Recent Development Table 81. Shandong Boshan Pharma Company Information Table 82. Shandong Boshan Pharma Business Overview Table 83. Shandong Boshan Pharma Perphenazine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Shandong Boshan Pharma Perphenazine Drug Product Portfolio Table 85. Shandong Boshan Pharma Recent Development Table 86. ZHPHARMA Company Information Table 87. ZHPHARMA Business Overview Table 88. ZHPHARMA Perphenazine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. ZHPHARMA Perphenazine Drug Product Portfolio Table 90. ZHPHARMA Recent Development Table 91. Viatris Company Information Table 92. Viatris Business Overview Table 93. Viatris Perphenazine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Viatris Perphenazine Drug Product Portfolio Table 95. Viatris Recent Development Table 96. Endo Company Information Table 97. Endo Business Overview Table 98. Endo Perphenazine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Endo Perphenazine Drug Product Portfolio Table 100. Endo Recent Development Table 101. North America Perphenazine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Perphenazine Drug Sales by Country (2021-2026) & (K Units) Table 103. North America Perphenazine Drug Sales Market Share by Country (2021-2026) Table 104. North America Perphenazine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Perphenazine Drug Sales Market Share Forecast by Country (2027-2032) Table 106. North America Perphenazine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Perphenazine Drug Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Perphenazine Drug Market Share by Country (2021-2026) Table 109. North America Perphenazine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Perphenazine Drug Market Share Forecast by Country (2027-2032) Table 111. Europe Perphenazine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Perphenazine Drug Sales by Country (2021-2026) & (K Units) Table 113. Europe Perphenazine Drug Sales Market Share by Country (2021-2026) Table 114. Europe Perphenazine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Perphenazine Drug Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Perphenazine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Perphenazine Drug Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Perphenazine Drug Market Share by Country (2021-2026) Table 119. Europe Perphenazine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Perphenazine Drug Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Perphenazine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Perphenazine Drug Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Perphenazine Drug Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Perphenazine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Perphenazine Drug Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Perphenazine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Perphenazine Drug Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Perphenazine Drug Market Share by Country (2021-2026) Table 129. Asia-Pacific Perphenazine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Perphenazine Drug Market Share Forecast by Country (2027-2032) Table 131. Latin America Perphenazine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Perphenazine Drug Sales by Country (2021-2026) & (K Units) Table 133. Latin America Perphenazine Drug Sales Market Share by Country (2021-2026) Table 134. Latin America Perphenazine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Perphenazine Drug Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Perphenazine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Perphenazine Drug Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Perphenazine Drug Market Share by Country (2021-2026) Table 139. Latin America Perphenazine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Perphenazine Drug Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Perphenazine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Perphenazine Drug Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Perphenazine Drug Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Perphenazine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Perphenazine Drug Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Perphenazine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Perphenazine Drug Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Perphenazine Drug Market Share by Country (2021-2026) Table 149. Middle East and Africa Perphenazine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Perphenazine Drug Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Perphenazine Drug Distributors List Table 154. Perphenazine Drug Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Perphenazine Drug Image Figure 2. Global Perphenazine Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Perphenazine Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Perphenazine Drug Sales (2021-2032) & (K Units) Figure 5. Oral Forms Image Figure 6. Global Oral Forms Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injectable Solution Image Figure 8. Global Injectable Solution Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Perphenazine Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Perphenazine Drug Market Share by Type 2025 VS 2032 Figure 11. North America Perphenazine Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America Perphenazine Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe Perphenazine Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe Perphenazine Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Perphenazine Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Perphenazine Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America Perphenazine Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Perphenazine Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Perphenazine Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Perphenazine Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Perphenazine Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Psychosis Image Figure 24. Global Psychosis Sales YoY Growth (2021-2032) & (K Units) Figure 25. Antiemetic Image Figure 26. Global Antiemetic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Perphenazine Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Perphenazine Drug Market Share by Application 2025 VS 2032 Figure 29. North America Perphenazine Drug Sales Market Share in Volume by Application in 2025 Figure 30. North America Perphenazine Drug Sales Market Share in Value by Application in 2025 Figure 31. Europe Perphenazine Drug Sales Market Share in Volume by Application in 2025 Figure 32. Europe Perphenazine Drug Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Perphenazine Drug Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Perphenazine Drug Sales Market Share in Value by Application in 2025 Figure 35. Latin America Perphenazine Drug Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Perphenazine Drug Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Perphenazine Drug Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Perphenazine Drug Sales Market Share in Value by Application in 2025 Figure 39. North America Perphenazine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Perphenazine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Perphenazine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Perphenazine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Perphenazine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Perphenazine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Perphenazine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Perphenazine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Perphenazine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Perphenazine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Perphenazine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Perphenazine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Perphenazine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Perphenazine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Perphenazine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Perphenazine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Perphenazine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Perphenazine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Perphenazine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Perphenazine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Perphenazine Drug Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Perphenazine Drug Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Forms
  • Injectable Solution
Applications
  • Psychosis
  • Antiemetic
Companies covered
  • Teva
  • Sandoz
  • Shandong Boshan Pharma
  • ZHPHARMA
  • Viatris
  • Endo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Perphenazine Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Perphenazine Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Perphenazine Drug Market by Type
  6. 1.3.1 Oral Forms
  7. 1.3.2 Injectable Solution
  8. 1.4 Global Perphenazine Drug Market Size by Type
  9. 1.4.1 Global Perphenazine Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Perphenazine Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Perphenazine Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Perphenazine Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Perphenazine Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Perphenazine Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Perphenazine Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Perphenazine Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Perphenazine Drug Industry Trends
  2. 2.2 Perphenazine Drug Industry Drivers
  3. 2.3 Perphenazine Drug Industry Opportunities and Challenges
  4. 2.4 Perphenazine Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Perphenazine Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Perphenazine Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Perphenazine Drug Price (2021-2026)
  4. 3.4 Global Perphenazine Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Perphenazine Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Perphenazine Drug Company, Product Type & Application
  7. 3.7 Global Perphenazine Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Perphenazine Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Perphenazine Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Perphenazine Drug Tier 1, Tier 2, and Tier 3
4 Perphenazine Drug Regional Status and Outlook
  1. 4.1 Global Perphenazine Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Perphenazine Drug Historic Market Size by Region
  3. 4.2.1 Global Perphenazine Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Perphenazine Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Perphenazine Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Perphenazine Drug Forecasted Market Size by Region
  7. 4.3.1 Global Perphenazine Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Perphenazine Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Perphenazine Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Perphenazine Drug by Application
  1. 5.1 Perphenazine Drug Market by Application
  2. 5.1.1 Psychosis
  3. 5.1.2 Antiemetic
  4. 5.2 Global Perphenazine Drug Market Size by Application
  5. 5.2.1 Global Perphenazine Drug Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Perphenazine Drug Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Perphenazine Drug Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Perphenazine Drug Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Perphenazine Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Perphenazine Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Perphenazine Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Perphenazine Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Perphenazine Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Perphenazine Drug Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sandoz
  8. 6.2.1 Sandoz Company Information
  9. 6.2.2 Sandoz Business Overview
  10. 6.2.3 Sandoz Perphenazine Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sandoz Perphenazine Drug Product Portfolio
  12. 6.2.5 Sandoz Recent Developments
  13. 6.3 Shandong Boshan Pharma
  14. 6.3.1 Shandong Boshan Pharma Company Information
  15. 6.3.2 Shandong Boshan Pharma Business Overview
  16. 6.3.3 Shandong Boshan Pharma Perphenazine Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shandong Boshan Pharma Perphenazine Drug Product Portfolio
  18. 6.3.5 Shandong Boshan Pharma Recent Developments
  19. 6.4 ZHPHARMA
  20. 6.4.1 ZHPHARMA Company Information
  21. 6.4.2 ZHPHARMA Business Overview
  22. 6.4.3 ZHPHARMA Perphenazine Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 ZHPHARMA Perphenazine Drug Product Portfolio
  24. 6.4.5 ZHPHARMA Recent Developments
  25. 6.5 Viatris
  26. 6.5.1 Viatris Company Information
  27. 6.5.2 Viatris Business Overview
  28. 6.5.3 Viatris Perphenazine Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Viatris Perphenazine Drug Product Portfolio
  30. 6.5.5 Viatris Recent Developments
  31. 6.6 Endo
  32. 6.6.1 Endo Company Information
  33. 6.6.2 Endo Business Overview
  34. 6.6.3 Endo Perphenazine Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Endo Perphenazine Drug Product Portfolio
  36. 6.6.5 Endo Recent Developments
7 North America by Country
  1. 7.1 North America Perphenazine Drug Sales by Country
  2. 7.1.1 North America Perphenazine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Perphenazine Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Perphenazine Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Perphenazine Drug Market Size by Country
  6. 7.2.1 North America Perphenazine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Perphenazine Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Perphenazine Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Perphenazine Drug Sales by Country
  2. 8.1.1 Europe Perphenazine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Perphenazine Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Perphenazine Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Perphenazine Drug Market Size by Country
  6. 8.2.1 Europe Perphenazine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Perphenazine Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Perphenazine Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Perphenazine Drug Sales by Country
  2. 9.1.1 Asia-Pacific Perphenazine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Perphenazine Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Perphenazine Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Perphenazine Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Perphenazine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Perphenazine Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Perphenazine Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Perphenazine Drug Sales by Country
  2. 10.1.1 South America Perphenazine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Perphenazine Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Perphenazine Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Perphenazine Drug Market Size by Country
  6. 10.2.1 South America Perphenazine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Perphenazine Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Perphenazine Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Perphenazine Drug Sales by Country
  2. 11.1.1 Middle East and Africa Perphenazine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Perphenazine Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Perphenazine Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Perphenazine Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Perphenazine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Perphenazine Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Perphenazine Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Perphenazine Drug Value Chain Analysis
  2. 12.1.1 Perphenazine Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Perphenazine Drug Production Mode & Process
  7. 12.2 Perphenazine Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Perphenazine Drug Distributors
  10. 12.2.3 Perphenazine Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst